ASSESSMENT OF RISK FACTORS IN THE TREATMENT AND PREVENTION OF TYPE 2 DIABETES MELLITUS
Keywords:
diabetes mellitus, treatment, metformin, glycaemic control, risk factors, prevention.Abstract
Type 2 diabetes mellitus (T2DM) is a common chronic metabolic disorder characterized by persistent hyperglycaemia resulting from impaired insulin secretion and reduced tissue sensitivity to insulin. According to the International Diabetes Federation’s 2025 data, 589 million people aged 20–79 years worldwide are living with diabetes, more than 250 million of whom remain unaware of their condition [2]. Timely glycaemic control reduces the risk of complications, including retinopathy, nephropathy, neuropathy, and cardiovascular disease [1].
References
1.American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S1–S377.
2.International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025.
3.Knowler W.C., Barrett-Connor E., Fowler S.E. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
4.Davies M.J., Aroda V.R., Collins B.S. et al. Management of hyperglycemia in type 2 diabetes, 2022. Diabetes Care. 2022;45(11):2753–2786.
5.UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–865.
6.Ermatov N. J. et al. Socio-hygienic analysis of risk factors in patients with diseases of the endocrine system. – 2023.